Rigel Pharmaceuticals, Inc.
Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Abstract:

The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.